NCT04708795View on ClinicalTrials.gov

Clinical Trial on Pharmacokinetic and Tolerability of AP701

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 11, 2020

Primary Completion Date

March 7, 2021

Study Completion Date

March 7, 2021

Conditions
PharmacokineticTolerabilitySafety
Interventions
DRUG

AP701

Preparation of Cannabis flowers (Cannabis flos)

Trial Locations (1)

D-83627

Phase I Unit of CannaXan GmbH, Warngau

All Listed Sponsors
lead

CannaXan GmbH

INDUSTRY

NCT04708795 - Clinical Trial on Pharmacokinetic and Tolerability of AP701 | Biotech Hunter | Biotech Hunter